Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.

Vanstokstraeten, R; Piérard, D; Crombé, F; De Geyter, D; Wybo, I; Muyldermans, A; Seyler, L; Caljon, B; Janssen, T; Demuyser, T

Vanstokstraeten, R; Piérard, D; Crombé, F; De Geyter, D; Wybo, I; Muyldermans, A; Seyler, L; Caljon, B; Janssen, T; Demuyser, T.

Afiliação

Vanstokstraeten R; Department of Microbiology and Infection Control, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium. robin.vanstokstraeten@uzbrussel.be.
Piérard D; Department of Microbiology and Infection Control, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Crombé F; Department of Microbiology and Infection Control, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
De Geyter D; Department of Microbiology and Infection Control, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Wybo I; Department of Microbiology and Infection Control, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Muyldermans A; Department of Microbiology and Infection Control, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Seyler L; Department of Infectious Diseases, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Caljon B; Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore) Platform, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Janssen T; Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore) Platform, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Demuyser T; Department of Microbiology and Infection Control, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

Sci Rep ; 13(1): 449, 2023 01 09.

Article em En | MEDLINE | ID: mdl-36624272

Assuntos

Infecções por Escherichia coli; Escherichia coli; Humanos; Escherichia coli/genética; Meropeném; Amicacina/farmacologia; Cefepima; Ceftazidima; Estudos Retrospectivos; Antibacterianos/farmacologia; Cefotaxima; Infecções por Escherichia coli/tratamento farmacológico; Infecções por Escherichia coli/microbiologia; Ciprofloxacina/farmacologia; Testes de Sensibilidade Microbiana; Genótipo; Fenótipo; Piperacilina; Tazobactam; Sequenciamento Completo do Genoma; Tobramicina; Amoxicilina; Gentamicinas; Ácido Clavulânico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escherichia coli / Infecções por Escherichia coli Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google